Patents Assigned to Eicosis, LLC
  • Co-crystal of sorafenib derivatives and process for preparation thereof
    Patent number: 11987542
    Abstract: The present disclosure provides compounds for the inhibition of soluble epoxide hydrolase and associate disease conditions, as well as a method of treating or preventing disorders in a subject by inhibition of soluble epoxide hydrolase.
    Type: Grant
    Filed: July 3, 2019
    Date of Patent: May 21, 2024
    Assignee: EicOsis, LLC
    Inventors: Bruce D. Hammock, Sung Hee Hwang, Karen M. Wagner, Cynthia B. McReynolds
  • Potent soluble epdxide hydrolase inhibitors
    Patent number: 10377744
    Abstract: The invention discloses a new series of inhibitors of soluble epoxide hydrolase (sEH) with improved physical properties that enhance their druglikeness to treat sEH associated diseases such as chronic diabetic neuropathic pain.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: August 13, 2019
    Assignee: Eicosis, LLC
    Inventors: Bruce D. Hammock, Kin Sing Stephen Lee, Ahmet Bora Inceoglu